There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
Principal Investigator | |
Principal Investigator's Name: | Sean Hong |
Institution: | NKGen Biotech |
Department: | Clinical |
Country: | |
Proposed Analysis: | Compared with healthy control, the level of plasma and CSF Biomarkers for Alzheimer's Disease: Tau, pTau, Amyloid Beta 42, Amyloid Beta 42/40, NF-L, GFAP, YKL-40. Change of those markers after the treatment of the current available AD drug. Other neuroinflammation markers are investigating for AD. |
Additional Investigators |